A recent study revealed that popular weight-loss drugs GLP-1 such as Ozempic, Wegovy and Zepbound produce lower weight loss ...

At 12 weeks, weight loss ranged from 2.6% to 11.3%, compared to a gain of 0.2% in the placebo group. Guggenheim analysts were ...

Side effects of the drug, tested as both a weekly injection and a daily pill, were mostly gastrointestinal with rates similar ...

Real-world study shows injectable GLP-1 drugs for obesity have lower weight loss due to treatment discontinuation.

Eli Lilly's drug, called eloralintide, helped some patients lose more than 11% of their body weight in three months.

People who take weight-loss drugs hoping to achieve the impressive results observed in large clinical trials may need to ...